Logical Therapeutics: Better medicine. It's only logical.

Business Development

Logical Therapeutics’ business model is largely predicated on in-licensing of assets, ranging from early pre-clinical to mid-stage clinical programs, in the inflammation space. Our programs have historically come from both academia and from other private companies. Logical Therapeutic’s expertise lies in the development of drugs from early concept through to Phase 2 clinical studies.

Our out-licensing activities target partnerships with larger pharmaceutical or biotechnology companies who bring go-to-market expertise and resources.

To learn more, please contact us at bd@logicaltx.com